Watch: What’s up with tranched deals in biotech?
Tranche is a French word meaning slice, and that’s pretty much what it means in the language of venture capital as well. When a company raises a huge sum of …
Read MoreTag: finance
With Amwell’s deal, the acquisition race heats up in telehealth
You’re reading the web edition of STAT Health Tech, our guide to how tech is transforming the life sciences. Sign up to get this newsletter delivered in your inbox every Tuesday and …
Read More
Watch: SPACs are all the rage, but what are they? STAT explains
Wall Street’s hottest new trend is a 1980s retread: Private firms are merging with so-called blank-check companies in order to go public without the pains and payments that come with …
Read More
Will you accept this capital investment? Biotech and health startups bet on a strange new reality show for crowdfunding
“Mount up! Let’s hear more about this unicorn.” So begins every episode of a new reality show called “Unicorn Hunters,” built around an outlandish twist on a well-worn premise: What …
Read More
There’s a gold rush in health tech. Here’s how the smart money stays ahead
Investors are pouring into the health tech sector, with venture funding roughly doubling in 2020. That’s good for individual companies, but when valuations begin to depart from reality, it takes …
Read More
Opinion: To create value, pharma companies should prioritize innovation, not shareholders
Biogen announced its quarterly earnings on April 22 and revealed it had repurchased $600 million of its shares in the first quarter — a majority (78%) of its operating cash …
Read More
‘Deeply problematic’: AmerisourceBergen rewards its CEO despite the ravages of the opioid crisis
You can file this under, “What opioid crisis?” In one of the more startling examples of tin-ear syndrome, AmerisourceBergen wants its shareholders to bless a $14.3 million pay package for …
Read More
Pharma’s ambitious new antibiotic venture hires a CEO to fix a ‘broken’ pipeline
Several months after a splashy announcement, an ambitious pharmaceutical industry venture to tackle antibiotic resistance has hired its first chief executive officer and received $140 million in additional funding commitments. …
Read More
Listen: 23andMe is going public, vaccine data abound, and Merck’s CEO is retiring
Is consumer DNA testing a good business? Are Covid-19 vaccines interchangeable? And how do you IQ-test an artificial intelligence? We discuss all that and more this week on “The Readout …
Read More